BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1880665)

  • 1. Pharmacokinetic and pharmacodynamic study of midazolam in children during esophagogastroduodenoscopy.
    Tolia V; Brennan S; Aravind MK; Kauffman RE
    J Pediatr; 1991 Sep; 119(3):467-71. PubMed ID: 1880665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and pharmacodynamics of midazolam after intravenous and intramuscular administration in alpacas.
    Aarnes TK; Fry PR; Hubbell JA; Bednarski RM; Lerche P; Chen W; Bei D; Liu Z; Lakritz J
    Am J Vet Res; 2013 Feb; 74(2):294-9. PubMed ID: 23363357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimizing sedation following major vascular surgery: a double-blind study of midazolam administered by continuous infusion.
    Miller DR; Martineau RJ; Hull KA; Vallée F; LeBel M
    Can J Anaesth; 1994 Sep; 41(9):782-93. PubMed ID: 7954994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and the pharmacodynamic action of midazolam in young and elderly patients undergoing tooth extraction.
    Platten HP; Schweizer E; Dilger K; Mikus G; Klotz U
    Clin Pharmacol Ther; 1998 May; 63(5):552-60. PubMed ID: 9630828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantification of the EEG effect of midazolam by aperiodic analysis in volunteers. Pharmacokinetic/pharmacodynamic modelling.
    Breimer LT; Hennis PJ; Burm AG; Danhof M; Bovill JG; Spierdijk J; Vletter AA
    Clin Pharmacokinet; 1990 Mar; 18(3):245-53. PubMed ID: 2323155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A placebo- and midazolam-controlled phase I single ascending-dose study evaluating the safety, pharmacokinetics, and pharmacodynamics of remimazolam (CNS 7056): Part II. Population pharmacokinetic and pharmacodynamic modeling and simulation.
    Wiltshire HR; Kilpatrick GJ; Tilbrook GS; Borkett KM
    Anesth Analg; 2012 Aug; 115(2):284-96. PubMed ID: 22253270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic-EEG effect relationship of midazolam in aging BN/BiRij rats.
    Hovinga S; Stijnen AM; Langemeijer MW; Mandema JW; van Bezooijen CF; Danhof M
    Br J Pharmacol; 1992 Sep; 107(1):171-7. PubMed ID: 1422570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous midazolam sedation in pediatric diagnostic upper digestive endoscopy. A prospective study in a general hospital.
    Verhage J; Mulder CJ; Willekens FL
    Rom J Gastroenterol; 2003 Dec; 12(4):273-6. PubMed ID: 14726970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The pharmacokinetics of midazolam following intramuscular administration].
    Behne M; Janshon G; Asskali F; Förster H
    Anaesthesist; 1989 Jun; 38(6):278-84. PubMed ID: 2764268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmacokinetic studies following intravenous and rectal administration of midazolam in children].
    Kraus GB; Gruber RG; Knoll R; Danner U
    Anaesthesist; 1989 Dec; 38(12):658-63. PubMed ID: 2619028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intranasal administration of midazolam: pharmacokinetic and pharmacodynamic properties and sedative potential.
    Fukuta O; Braham RL; Yanase H; Kurosu K
    ASDC J Dent Child; 1997; 64(2):89-98. PubMed ID: 9188997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactions between midazolam and remifentanil during monitored anesthesia care.
    Avramov MN; Smith I; White PF
    Anesthesiology; 1996 Dec; 85(6):1283-9. PubMed ID: 8968175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized, controlled, cross-over clinical trial comparing intravenous midazolam sedation with nitrous oxide sedation in children undergoing dental extractions.
    Wilson KE; Girdler NM; Welbury RR
    Br J Anaesth; 2003 Dec; 91(6):850-6. PubMed ID: 14633757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population pharmacokinetics and metabolism of midazolam in pediatric intensive care patients.
    de Wildt SN; de Hoog M; Vinks AA; van der Giesen E; van den Anker JN
    Crit Care Med; 2003 Jul; 31(7):1952-8. PubMed ID: 12847388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics, pharmacodynamics, and tolerability of USL261, midazolam nasal spray: Randomized study in healthy geriatric and non-geriatric adults.
    Berg AK; Myrvik MJ; Van Ess PJ
    Epilepsy Behav; 2017 Jun; 71(Pt A):51-59. PubMed ID: 28544992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of midazolam after intravenous administration to horses.
    Hubbell JA; Kelly EM; Aarnes TK; Bednarski RM; Lerche P; Liu Z; Lakritz J
    Equine Vet J; 2013 Nov; 45(6):721-5. PubMed ID: 23489241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and pharmacodynamics of midazolam administered as a concentrated intranasal spray. A study in healthy volunteers.
    Knoester PD; Jonker DM; Van Der Hoeven RT; Vermeij TA; Edelbroek PM; Brekelmans GJ; de Haan GJ
    Br J Clin Pharmacol; 2002 May; 53(5):501-7. PubMed ID: 11994056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conscious sedation by oral administration of midazolam in paediatric dental treatment.
    Erlandsson AL; Bäckman B; Stenström A; Stecksén-Blicks C
    Swed Dent J; 2001; 25(3):97-104. PubMed ID: 11813451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The pharmacokinetics of midazolam in various kinds of anesthesia].
    Behne M; Zobel R; Asskali F; Förster H; Kessler P; Seiz W
    Anaesthesist; 1987 Nov; 36(11):634-9. PubMed ID: 3425871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of flumazenil and midazolam.
    Jones RD; Chan K; Roulson CJ; Brown AG; Smith ID; Mya GH
    Br J Anaesth; 1993 Mar; 70(3):286-92. PubMed ID: 8471371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.